Altered secretory leukocyte protease inhibitor expression in the uterine decidua of tubal compared with intrauterine pregnancy
Author(s) -
D.M. Dalgetty,
Jean–Michel Sallenave,
Hilary Critchley,
Alistair Williams,
W.Y. Tham,
A.E. King,
Andrew W. Horne
Publication year - 2008
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/den130
Subject(s) - decidua , pregnancy , protease inhibitor (pharmacology) , andrology , protease , uterus , endometrium , medicine , gynecology , biology , obstetrics , endocrinology , immunology , placenta , enzyme , fetus , human immunodeficiency virus (hiv) , biochemistry , antiretroviral therapy , viral load , genetics
The role of the innate immune system in tubal implantation remains undefined. This study compared expression of two key mediators of innate immunity, secretory leukocyte protease inhibitor (SLPI) and elafin, in the uterine decidua of women with intrauterine and tubal pregnancies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom